Ensol Biosciences Inc. (XKON:140610)
9,450.00
-300.00 (-3.08%)
At close: Oct 15, 2026
| Market Cap | 133.27B -31.1% |
| Revenue (ttm) | 537.46M +208.9% |
| Net Income | -5.40B |
| EPS | -644.00 |
| Shares Out | 14.38M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 5,550 |
| Open | 9,600.00 |
| Previous Close | 9,750.00 |
| Day's Range | 9,000.00 - 9,600.00 |
| 52-Week Range | 8,750.00 - 17,900.00 |
| Beta | 0.70 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |